Diabetes und Schwangerschaft

ZUSAMMENFASSUNG

Schwangerschaften mit präkonzeptionell bekanntem Typ-1- und Typ-2-Diabetes sind Hochrisiko-Schwangerschaften und bedürfen einer interdisziplinären Betreuung. Kinder diabetischer Mütter haben ein im Mittel 1,5- bis 3-fach erhöhtes Risiko für angeborene Fehlbildungen, Frühgeburtlichkeit, Hypertrophie, Atemstörungen, Plexusparese und Asphyxie. Das Risiko für Totgeburt und Tod in den ersten 7 Lebenstagen ist bei prägravidem Diabetes erhöht. Die mit Abstand häufigste Komplikation bei Neugeborenen diabetischer Mütter ist die postnatale Hypoglykämie. Diabetesassoziierte Begleiterkrankungen und maternale Adipositas sind unabhängige Risikofaktoren für Schwangerschaftskomplikationen und ein ungünstiges fetales Outcome. Für die Blutglukoseeinstellung während der Schwangerschaft wurde ein klarer Zusammenhang höherer Werte mit ungünstigen fetalen und maternalen Ereignissen gezeigt. Analoginsuline sind mittlerweile die Insuline der Wahl. Darüber hinaus konnte eine Überlegenheit einer CGM-Versorgung während der Schwangerschaft gegenüber der konventionellen Blutglukosemessung gezeigt werden. Die Rate an Sektiones ist bei Frauen mit Diabetes nach wie vor gegenüber der Grundgesamtheit in der Perinatalstatistik deutlich erhöht. Evidenzbasierte Erkenntnisse zum intrapartalen Vorgehen liegen nicht vor. Die Einstellungsziele orientieren sich daher an den während der Schwangerschaft geltenden Zielen.

Publikationsverlauf

Artikel online veröffentlicht:
09. Dezember 2022

• Literatur

• 1 American College of Obstetricians and Gynecologists (ACOG) ACOG Committee Opinion number 315, September 2005. Obesity in pregnancy. Obstet Gynecol 2005; 106: 671-675
• 2 Barbour LA. Changing perspectives in pre-existing diabetes and obesity in pregnancy: Maternal and infant short- and long-term outcomes. Curr Opin Endocrinol Diabetes Obes 2014; 21: 257-263
• 3 Metwally M, Ong KJ, Ledger WL. et al Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril 2008; 90: 714-726
• 4 van der Steeg JW, Steures P, Eijkemans MJC. et al Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod 2008; 23: 324-328
• 5 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). S2k-Leitlinie Prävention und Therapie der Frühgeburtlichkeit Version 1.0. Stand Februar 2019. 2018. Im Internet (Stand: 13.06.2020) https://www.awmf.org/leitlinien/detail/ll/015-025.html
• 6 Araujo J, Brandão LAC, Guimarães RL. et al Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes. Pediatr Diabetes 2008; 09: 272-276
• 7 Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up. J Clin Endocrinol Metab 2003; 88: 2983-2992
• 8 Hunger-Battefeld W, Fath K, Mandecka A. et al Prävalenz eines polyglandulären Autoimmunsyndroms bei Patienten mit Diabetes mellitus Typ 1. Med Klin (Munich) 2009; 104: 183-191
• 9 Rabe M, Groten T, Dawczynski K. et al Tranzplazentarer Autoantikörpertransfer bei Schwangeren mit Typ 1 Diabetes mellitus bzw. polyglandulärem Autoimmunsyndrom. Diabetologie 2015; 10: 322-328
• 10 Bell R, Glinianaia SV, Tennant PWG. et al Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: A population-based cohort study. Diabetologia 2012; 55: 936-947
• 11 Cyganek K, Skupien J, Katra B. et al Risk of macrosomia remains glucosedependent in a cohort of women with pregestational type 1 diabetes and good glycemic control. Endocrine 2017; 55: 447-455
• 12 Holmes VA, Young IS, Patterson CC. et al Optimal glycemic control, preeclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 2011; 34: 1683-1688
• 13 Ludvigsson JF, Neovius M, Söderling J. et al Maternal Glycemic Control in Type 1 Diabetes and the Risk for Preterm Birth: A Population-Based Cohort Study. Ann Intern Med 2019; 170: 691-701
• 14 Tennant PWG, Glinianaia SV, Bilous RW. et al Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: A population-based study. Diabetologia 2014; 57: 285-294
• 15 Feig DS, Corcoy R, Donovan LE. et al Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial. Diabetes Care 2018; 41: 2471-2479
• 16 Glinianaia SV, Tennant PWG, Bilous RW. et al HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: A populationbased cohort study. Diabetologia 2012; 55: 3193-3203
• 17 Mackin ST, Nelson SM, Wild SH. et al Factors associated with stillbirth in women with diabetes. Diabetologia 2019; 62: 1938-1947
• 18 Björklund AO, Adamson UK, Almström NH. et al Effects of hypoglycaemia on fetal heart activity and umbilical artery Doppler velocity waveforms in pregnant women with insulin-dependent diabetes mellitus. Br J Obstet Gynaecol 1996; 103: 413-420
• 19 Naik D, Hesarghatta Shyamasunder A, Doddabelavangala Mruthyunjaya M. et al Masked hypoglycemia in pregnancy. J Diabetes 2017; 09: 778-786
• 20 Reece EA, Hagay Z, Roberts AB. et al Fetal Doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic women. Am J Obstet Gynecol 1995; 172: 151-155
• 21 ter Braak EWMT, Evers IM, Willem Erkelens D. et al Maternal hypoglycemia during pregnancy in type 1 diabetes: Maternal and fetal consequences. Diabetes Metab Res Rev 2002; 18: 96-105
• 22 Lorenzen T, Pociot F, Johannesen J. et al A population-based survey of frequencies of self-reported spontaneous and induced abortions in Danish women with Type 1 diabetes mellitus. Danish IDDM Epidemiology and Genetics Group. Diabet Med 1999; 16: 472-476
• 23 Mills JL. Malformations in infants of diabetic mothers. Teratology 1982; 25: 385-394
• 24 Rosenn B, Miodovnik M, Combs CA. et al Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994; 84: 515-520
• 25 Sutherland HW, Pritchard CW. Increased incidence of spontaneous abortion in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 1987; 156: 135-138
• 26 Becerra JE, Khoury MJ, Cordero JF. et al Diabetes mellitus during pregnancy and the risks for specific birth defects: A population-based casecontrol study. Pediatrics 1990; 85: 1-9
• 27 Chou H-H, Chiou M-J, Liang F-W. et al Association of maternal chronic disease with risk of congenital heart disease in offspring. CMAJ 2016; 188: E438-E446
• 28 Zhao E, Zhang Y, Zeng X. et al Association between maternal diabetes mellitus and the risk of congenital malformations: A meta-analysis of cohort studies. Drug Discov Ther 2015; 09: 274-281
• 29 Vinceti M, Malagoli C, Rothman KJ. et al Risk of birth defects associated with maternal pregestational diabetes. Eur J Epidemiol 2014; 29: 411-418
• 30 Callec R, Perdriolle-Galet E, Sery G-A. et al Type 2 diabetes in pregnancy: Rates of fetal malformations and level of preconception care. J Obstet Gynaecol 2014; 34: 648-649
• 31 Evers IM, Valk HW de, Visser GHA. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ 2004; 328: 915
• 32 Hoang TT, Marengo LK, Mitchell LE. et al Original Findings and Updated Meta-Analysis for the Association Between Maternal Diabetes and Risk for Congenital Heart Disease Phenotypes. Am J Epidemiol 2017; 186: 118-128
• 33 Liu S, Joseph KS, Lisonkova S. et al Association between maternal chronic conditions and congenital heart defects: A population-based cohort study. Circulation 2013; 128: 583-589
• 34 Schaefer-Graf UM, Buchanan TA, Xiang A. et al Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000; 182: 313-320
• 35 Simeone RM, Devine OJ, Marcinkevage JA. et al Diabetes and congenital heart defects: A systematic review, meta-analysis, and modeling project. Am J Prev Med 2015; 48: 195-204
• 36 Slot A, Eriksen NB, Ringholm L. et al Congenital heart defects in offspring of women with Type 2 diabetes – a systematic review. Dan Med J 2019; 66: A5543
• 37 Martínez-Frías ML, Rodríguez-Pinilla E, Bermejo E. et al Epidemiological evidence that maternal diabetes does not appear to increase the risk for Down syndrome. Am J Med Genet 2002; 112: 335-337
• 38 Wu Y, Liu B, Sun Y. et al Association of Maternal Prepregnancy Diabetes and Gestational Diabetes Mellitus With Congenital Anomalies of the Newborn. Diabetes Care 2020; 43: 2983-2990
• 39 Correa A, Botto L, Liu Y. et al Do multivitamin supplements attenuate the risk for diabetes-associated birth defects?. Pediatrics 2003; 111: 1146-1151
• 40 Li K, Yang C, Fan J. et al Prepregnancy body mass index, gestational weight gain, and maternal prepartum inflammation in normal pregnancies: findings from a Chinese cohort. BMC Pregnancy Childbirth 2022; 22: 531
• 41 Jovanovic L, Knopp RH, Kim H. et al Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: Evidence for a protective adaptation in diabetes. Diabetes Care 2005; 28: 1113-1117
• 42 Xiang L-J, Wang Y, Lu G-Y. et al Association of the presence of microangiopathy with adverse pregnancy outcome in type 1 diabetes: A metaanalysis. Taiwan J Obstet Gynecol 2018; 57: 659-664
• 43 Acolet D. Description of the babies and Standards of care for the babies. In: Macintosh M, Hrsg. Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002–2003, England, Wales and Northern Ireland. London: CEMACH; 2005: 37-49 Zugriff am 28.06.2022 unter https://elearning.rcog.org.uk//sites/default/files/Diabetes%20and%20other%20endocrinopathies/CEMACH_Pregnancy_type_1_2_diabetes.pdf
• 44 Boulot P, Chabbert-Buffet N, d’Ercole C. et al French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003; 26: 2990-2993
• 45 Chaudhry T, Ghani AM, Mehrali TH. et al A comparison of foetal and labour outcomes in Caucasian and Afro-Caribbean women with diabetes in pregnancy. Int J Clin Pract 2004; 58: 932-936
• 46 Clausen TD, Mathiesen E, Ekbom P. et al Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005; 28: 323-328
• 47 Cundy T, Gamble G, Townend K. et al Perinatal mortality in Type 2 diabetes mellitus. Diabet Med 2000; 17: 33-39
• 48 Dunne F, Brydon P, Smith K. et al Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med 2003; 20: 734-738
• 49 Poston L, Caleyachetty R, Cnattingius S. et al Preconceptional and maternal obesity: Epidemiology and health consequences. Lancet Diabetes Endocrinol 2016; 04: 1025-1236
• 50 American Diabetes Association (ADA) 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43 (Suppl. 01) S14-S31
• 51 Harreiter J, Simmons D, Desoye G. et al IADPSG and WHO 2013 Gestational Diabetes Mellitus Criteria Identify Obese Women With Marked Insulin Resistance in Early Pregnancy. Diabetes Care 2016; 39: e90-e92
• 52 Ray JG, O’Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: A meta-analysis. QJM 2001; 94: 435-444
• 53 Garcia-Patterson A, Corcoy R, Rigla M. et al Does preconceptional counselling in diabetic women influence perinatal outcome?. Ann Ist Super Sanita 1997; 33: 333-336
• 54 Willhoite MB, Bennert JR HW, Palomaki GE. et al The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 1993; 16: 450-455
• 55 American Diabetes Association (ADA) 13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41 (Suppl. 01) S137-S143
• 56 Lindsay RS, Loeken MR. Metformin use in pregnancy: Promises and uncertainties. Diabetologia 2017; 60: 1612-1619
• 57 Balsells M, Garcia-Patterson A, Sola I. et al Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-analysis. BMJ 2015; 350: h102
• 58 Camelo Castillo W, Boggess K, Stürmer T. et al Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes. JAMA Pediatr 2015; 169: 452-458
• 59 National Institute for Health and Care Excellence (NICE) Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. NICE guideline (NG 3). 2015
• 60 Ainuddin JA, Karim N, Zaheer S. et al Metformin treatment in type 2 diabetes in pregnancy: An active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy. J Diabetes Res 2015; 2015: 325851
• 61 Tieu J, Coat S, Hague W. et al Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes. Cochrane Database Syst Rev 2017; 10: CD007724
• 62 Rowan JA, Rush EC, Obolonkin V. et al Metformin in gestational diabetes: The offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011; 34: 2279-2284
• 63 Rowan JA, Rush EC, Plank LD. et al Metformin in gestational diabetes: The offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care 2018; 06: e000456
• 64 Hanem LGE, Stridsklev S, Juliusson PB. et al Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs. J Clin Endocrinol Metab 2018; 103: 1612-1621
• 65 Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis. PLoS Med 2019; 16: e1002848
• 66 Feig DS, Donovan LE, Zinman B. et al Metformin in women with type 2 diabetes in pregnancy (MiTy): A multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2020; 08: 834-844
• 67 Zhang R, Han S, Chen G-C. et al Effects of low-glycemic-index diets in pregnancy on maternal and newborn outcomes in pregnant women: A meta-analysis of randomized controlled trials. Eur J Nutr 2018; 57: 167-177
• 68 Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: A meta-analysis. Fertil Steril 2006; 86: 658-663
• 69 Norgaard SK, Nichum VL, Barfred C. et al Use of the smartphone application “Pregnant with Diabetes”. Dan Med J 2017; 64: A5417
• 70 Blumer I, Hadar E, Hadden DR. et al Diabetes and pregnancy: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013; 98: 4227-4249
• 71 Brown J, Ceysens G, Boulvain M. Exercise for pregnant women with preexisting diabetes for improving maternal and fetal outcomes. Cochrane Database Syst Rev 2017; 12: CD012696
• 72 American Diabetes Association (ADA) 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43 (Suppl. 01) S183-S192
• 73 Mackensen F, Paulus WE, Max R. et al Ocular changes during pregnancy. Dtsch Arztebl Int 2014; 111: 567-575 quiz 576
• 74 Joint British Diabetes Societies for Inpatient Care (JBDS–IP). Management of glycaemic control in pregnant women with diabetes on obstetric wards and delivery units: May 2017. 2017. https://www.diabetes.org.uk/professionals/resources/shared-practice/inpatient-and-hospital-care/joint-british-diabetes-society-for-inpatient-care/management-of-glycaemic-control-in-pregnant-women-with-diabetes-on-obstetric-wards-and-delivery-units (letzter Zugriff am 14.11.2022)